Inhibitory effects of shRNA targeting layilin on adhesion and invasion behavior of human lung adenocarcinoma A549 cells induced by hyaluronan in vitro

Chinese Journal of Lung Cancer

Volumn 9, Issue 3, 2006, Pages 236-240

  Zhuo, Wenlei ^a   Wang, Yan ^a   Chen, Zhengtang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

A549 cell line; Adhesion; Invasion; Layilin; RNA interference

Indexed keywords

HYALURONIC ACID DERIVATIVE; LAYILIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ARTICLE; CARCINOMA CELL; CELL ADHESION; CELL FUNCTION; CELL INVASION; CELL MEMBRANE PERMEABILITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LUNG CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

EID: 33745742187     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bono P, Rubin K, Higgins JM, et al. Layilin, a novel integral membrane protein, is a hyaluronan receptor. Mol Biol Cell 2001, 12(4):891-900.
2. Matsui Y, Inomata M, Izumi K, et al. Hyaluronic acid stimulates tumor-cell proliferation at wound sites. Gastrointest Endosc, 2004, 60(4):539-543.
3. Bourguignon LY, Gilad E, Rothman K, et al. Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression. J Biol Chem, 2005, 280 (12):11961-11972.
4. Carpenter PM, Dao AV. The role of hyaluronan in mesothelium-induced motility of ovarian carcinoma cells. Anticancer Res, 2003, 23(5A):3985-3990.
5. Bourguignon LY, Singleton PA, Zhu H, et al. Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression. J Biol Chem, 2003, 278(32):29420-29434.
6. Laurich C, Wheeler MA, Iida J, et al. Hyaluronan mediates adhesion of metastatic colon carcinoma cells. J Surg Res, 2004, 122 (1):70-74.
7. Simpson MA, Wilson CM, McCarthy JB. Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice. Am J Pathol, 2002, 161(3):849-857.
8. Shuster S, Frost GI, Csoka AB, et al. Hyaluronidase reduces human breast cancer xenografts in SCID mice. Int J Cancer, 2002, 102 (2):192-197.
9. Adamia S, Maxwell CA, Pilarski LM. Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer. Curr Drug Targets Cardiovasc Haematol Disord, 2005, 5(1):3-14.
10. Zhuo WL, Chen ZT. Hyaladherin and tumor. Chongqing Med J, 2005, 34(6):936-939.
11. Cambi A, Figdor CG. Dual function of C-type lectin-like receptors in the immune system. Curr Opin Cell Biol, 2003, 15(5):539-546.
12. Bono P, Cordero E, Johnson K, et al. Layilin, a cell surface hyaluronan receptor, interacts with merlin and radixin. Exp Cell Res, 2005, 308(1):177-187.
13. Bakolitsa C, Cohen DM, Bankston LA, et al. Structural basis for vinculin activation at sites of cell adhesion. Nature. 2004, 430 (6999):583-586.
14. Tadokoro S, Shattil SJ, Elo K, et al. Talin binding to integrin beta tails: a final common step in integrin activation. Science, 2003, 302(5642):103-106.
15. Schercr L, Rossi JJ. Recent applications of RNAi in mammalian systems. Curr Pharm Biotechnol, 2004, 5(4):355-360.